marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Vanda Pharmaceuticals Financial Ratios 2011-2024 | VNDA
Annual Financial Ratios Vanda Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
92.9 | 65.8 | 26.3 | 30.6 | 6.0 | 56.9 | -46.6 | -32.1 | -9.0 | 19.2 | -19.6 | -4.4 | -14.1 |
P/S |
1.2 | 1.6 | 3.2 | 2.9 | 3.0 | 7.4 | 4.4 | 4.0 | 3.3 | 7.7 | 11.7 | 3.7 | 4.4 |
EPS |
0.0 | 0.1 | 0.6 | 0.4 | 2.2 | 0.5 | -0.3 | -0.4 | -0.9 | 0.6 | -0.7 | -1.0 | -0.3 |
EV (Enterprise Value) |
201 M | 385 M | 908 M | 734 M | 719 M | 1.43 B | 765 M | 616 M | 390 M | 337 M | 431 M | 159 M | 200 M |
EBITDA per Share |
-0.23 | 0.13 | 0.78 | 0.53 | 0.458 | 0.457 | -0.339 | -0.176 | -0.644 | -1.59 | -0.623 | -0.947 | -0.328 |
EV/EBITDA |
20.0 | 26.1 | 26.6 | 59.0 | -45.6 | -70.4 | -11.4 | -5.9 | -17.5 | -1.3 | -5.5 | ||
PEG |
-1.56 | -1.29 | -1.66 | -0.77 | 0.02 | 0.23 | -3.18 | -0.57 | 0.03 | 0.1 | -0.62 | 0.02 | 0.06 |
P/B |
0.4 | 0.8 | 1.7 | 1.6 | 1.7 | 5.2 | 5.5 | 4.4 | 2.7 | 2.4 | 9.0 | 12.4 | 4.1 |
P/CF |
18.2 | 12.9 | 13.6 | 13.8 | 15.4 | 310.6 | -198.7 | -60.8 | 36.3 | -4.3 | -10.0 | -2.6 | -4.8 |
ROE % |
0.46 | 1.19 | 6.57 | 5.15 | 28.12 | 9.15 | -11.85 | -13.71 | -29.97 | 12.55 | -45.90 | -279.29 | -29.28 |
ROA % |
0.39 | 0.99 | 5.58 | 4.37 | 23.89 | 7.59 | -7.58 | -8.56 | -18.71 | 11.76 | -14.13 | -20.42 | -5.37 |
ROCE % |
-2.56 | 1.20 | 8.35 | 6.01 | 5.38 | 7.79 | -12.51 | -11.60 | -24.85 | -35.11 | -18.46 | -27.35 | -7.09 |
Current Ratio |
6.3 | 5.9 | 6.7 | 6.7 | 6.0 | 5.6 | 2.4 | 3.5 | 3.2 | 18.2 | 4.1 | 3.9 | 4.9 |
DSO |
64.1 | 47.3 | 42.5 | 41.5 | 42.4 | 54.4 | 38.9 | 50.7 | 54.2 | 26.6 | 23.3 | 16.1 | 18.9 |
DIO |
31.5 | 16.7 | 16.4 | 18.9 | 17.0 | 17.7 | 17.2 | 11.5 | 20.1 | 1134.0 | - | 161.3 | - |
DPO |
- | - | - | - | - | - | 415.9 | 239.2 | 245.3 | 192.5 | - | 812.1 | - |
Operating Cycle |
95.6 | 64.0 | 58.9 | 60.4 | 59.4 | 72.1 | 56.1 | 62.2 | 74.4 | 1160.6 | - | 177.4 | - |
Cash Conversion Cycle |
95.6 | 64.0 | 58.9 | 60.4 | 59.4 | 72.1 | -359.8 | -177.0 | -170.9 | 968.0 | - | -634.7 | - |
All numbers in USD currency
Quarterly Financial Ratios Vanda Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.09 | -0.08 | - | - | 0.03 | 0.06 | - | 0.06 | 0.05 | -0.11 | - | 0.14 | 0.17 | 0.16 | 0.15 | 0.11 | 0.16 | 0.01 | 0.08 | 1.88 | 0.22 | -0.01 | 0.2 | 0.14 | 0.09 | 0.07 | -0.04 | -0.1 | -0.03 | -0.17 | -0.01 | -0.01 | -0.11 | -0.29 | -0.35 | -0.22 | -0.13 | -0.24 | 1.85 | -0.04 | -0.64 | -0.79 | -0.23 | -0.17 | -0.11 | -0.15 | -0.23 | -0.19 | -0.28 | -0.28 | -0.2 | -0.11 | -0.05 | - |
EBITDA per Share |
-0.16 | -0.14 | - | -0.1 | -0.04 | 0.04 | - | 0.08 | 0.07 | -0.13 | - | 0.21 | 0.23 | 0.19 | 0.19 | 0.16 | 0.18 | - | 0.08 | 0.22 | 0.2 | -0.03 | 0.17 | 0.14 | 0.09 | 0.06 | -0.05 | -0.09 | -0.03 | -0.17 | -0.01 | - | -0.1 | -0.28 | -0.35 | -0.21 | -0.12 | -0.24 | 1.68 | -0.03 | -0.63 | -0.79 | -0.23 | -0.16 | -0.11 | -0.16 | -0.23 | -0.17 | -0.27 | -0.28 | -0.21 | -0.11 | -0.05 | - |
ROE % |
-1.77 | -0.50 | 0.91 | 1.55 | 2.16 | 2.38 | -0.14 | 1.43 | 2.38 | 3.88 | 5.43 | 7.24 | 6.97 | 6.89 | 5.15 | 4.37 | 27.49 | 28.37 | 28.12 | 30.85 | 9.02 | 7.89 | 9.15 | 3.99 | -2.07 | -4.92 | -11.85 | -10.91 | -7.77 | -10.12 | -13.71 | -24.38 | -31.16 | -31.69 | -29.97 | 24.51 | 30.73 | 21.37 | 12.55 | -48.36 | -59.72 | -53.98 | -47.72 | -94.46 | -135.98 | -209.15 | -279.29 | -231.49 | -186.90 | -110.07 | -29.28 | -9.18 | -4.01 | 0.41 |
ROA % |
-1.48 | -0.41 | 0.76 | 1.29 | 1.79 | 0.49 | -1.60 | -0.26 | 1.62 | 3.32 | 4.63 | 6.17 | 5.94 | 5.88 | 4.37 | 3.71 | 23.36 | 24.10 | 23.89 | 26.13 | 7.53 | 6.54 | 7.59 | 3.58 | -0.80 | -2.93 | -7.58 | -6.97 | -4.96 | -6.41 | -8.56 | -15.22 | -19.46 | -19.79 | -18.71 | 28.84 | 32.45 | 22.41 | 11.76 | -34.25 | -37.19 | -26.99 | -14.69 | -13.99 | -14.15 | -17.70 | -20.42 | -18.75 | -16.50 | -11.32 | -5.37 | -1.68 | -0.73 | 0.07 |
ROCE % |
-6.11 | -4.61 | -1.26 | -0.50 | 1.36 | 2.57 | -0.09 | 2.10 | 3.54 | 5.43 | 6.97 | 9.28 | 8.80 | 8.25 | 6.01 | 4.74 | 5.65 | 6.03 | 5.55 | 7.84 | 7.49 | 6.50 | 7.89 | 2.93 | -3.08 | -5.96 | -12.87 | -11.73 | -8.48 | -10.66 | -14.14 | -24.84 | -31.51 | -31.97 | -30.21 | 24.32 | 30.60 | 21.26 | 12.47 | -48.52 | -59.93 | -54.23 | -48.05 | -95.29 | -137.44 | -211.34 | -284.96 | -237.71 | -193.08 | -115.97 | -31.99 | -9.84 | -4.52 | 0.02 |
Current Ratio |
6.2 | 6.0 | 6.3 | 6.5 | 6.3 | 5.9 | 5.9 | 5.9 | - | 6.0 | 6.7 | 6.7 | 6.6 | 7.2 | 6.7 | 6.7 | 6.7 | 6.7 | 6.6 | 6.6 | 6.6 | 6.6 | 5.9 | 5.9 | 5.9 | 5.9 | 2.8 | 2.8 | 2.8 | 2.8 | 2.7 | 2.7 | 2.7 | 2.7 | 2.7 | 2.7 | 2.7 | 2.7 | 15.8 | 15.8 | 15.8 | 15.8 | 1.4 | 1.4 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | 1.1 | 1.2 | 1.2 | 1.2 | 1.2 |
DSO |
81.0 | 68.7 | - | 73.9 | 57.6 | 42.4 | - | 20.5 | 21.6 | 47.7 | - | 51.1 | 46.1 | 44.8 | 40.5 | 45.5 | 44.1 | 44.4 | 39.5 | 40.5 | 40.7 | 52.7 | 49.5 | 53.5 | 55.5 | 48.5 | 36.3 | 38.9 | 38.2 | 46.2 | 48.4 | 48.1 | 51.3 | 50.2 | 46.8 | 52.6 | 54.0 | 41.2 | 21.7 | 22.6 | 30.7 | 28.4 | 21.1 | 21.3 | 22.3 | 18.1 | 13.5 | 12.9 | 12.7 | 15.6 | 17.6 | 18.5 | 19.9 | - |
DIO |
55.1 | 47.2 | - | 31.1 | 28.5 | 22.0 | - | 11.5 | 9.7 | 18.6 | - | 13.1 | 16.8 | 20.0 | - | 19.8 | 20.0 | 21.2 | - | 15.3 | 16.3 | 19.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
136.2 | 115.9 | - | 105.0 | 86.1 | 64.3 | - | 32.0 | 31.3 | 66.4 | - | 64.3 | 62.9 | 64.8 | 40.5 | 65.2 | 64.0 | 65.6 | 39.5 | 55.8 | 57.1 | 71.8 | 49.5 | 53.5 | 55.5 | 48.5 | 36.3 | 38.9 | 38.2 | 46.2 | 48.4 | 48.1 | 51.3 | 50.2 | 46.8 | 52.6 | 54.0 | 41.2 | 21.7 | 22.6 | 30.7 | 28.4 | 21.1 | 21.3 | 22.3 | 18.1 | 13.5 | 12.9 | 12.7 | 15.6 | 17.6 | 18.5 | 19.9 | - |
Cash Conversion Cycle |
136.2 | 115.9 | - | 105.0 | 86.1 | 64.3 | - | 32.0 | 31.3 | 66.4 | - | 64.3 | 62.9 | 64.8 | 40.5 | 65.2 | 64.0 | 65.6 | 39.5 | 55.8 | 57.1 | 71.8 | 49.5 | 53.5 | 55.5 | 48.5 | 36.3 | 38.9 | 38.2 | 46.2 | 48.4 | 48.1 | 51.3 | 50.2 | 46.8 | 52.6 | 54.0 | 41.2 | 21.7 | 22.6 | 30.7 | 28.4 | 21.1 | 21.3 | 22.3 | 18.1 | 13.5 | 12.9 | 12.7 | 15.6 | 17.6 | 18.5 | 19.9 | - |
All numbers in USD currency